期刊文献+

对氧磷酯酶基因多态性与糖尿病肾病的关系 被引量:7

Relationship between paraoxonase 2 A148G polymorphism and diabetic nephropathy
原文传递
导出
摘要 目的 探讨对氧磷酯酶2(PON2)基因A148G多态性与糖尿病肾病的关系。方法(1)用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析法探查PON2基因A148G多态性在正常对照组、单纯2型糖尿病组、糖尿病肾病组中的基因频率分布;(2)放射免疫法检测血清免疫反应性胰岛素(IRI)、C肽(C-P)水平。结果(1)糖尿病肾病组GG基因型和G等位基因频率明显高于单纯2型糖尿病组(x2=4.26 P<0.05,X2=4.89 P<0.05)和正常对照组(x2=4.79 P<0.05,x2=5.49P<0.01);(2)基因型为GC的糖尿病患者空腹血糖浓度高于基因型为GA和AA的糖尿病患者的空腹血糖浓度(F=3.90 P<0.05,F=4.23 P<0.05);(3)Logistic回归分析表明 GG基因型是糖尿病肾病的独立变异危险因素(P<0.05)。结论PON2基因多态性与糖尿病肾病的发生有关。 Objective To determine whether the paraoxonase2 (PON2) gene A148G polymorphism is associated with the pathogenesis of nephropathy in type 2 diabetes mellitus patients (DN) . Methods PON2 genotype distribution and allele frequency were examined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) . Serum immune reactive insulin (IRI) and C-peptide (C-P) concentrations were measured by radioimmunity. Results GG genotype and G allele frequency were higher in DN group than that in simple type 2 diabetes mellitus group (x2 =4. 26 P < 0. 05, x2 =4. 89 P < 0. 05) and normal control group(x2 =4. 79 P < 0. 05, X2 = 5.49 P <0.05). The subjects with GG genotype had higher fasting plasma glucose concentration than those with GA and AA genotypes ( F = 3. 90 P < 0. 05, F = 4.23 P < 0. 05). Logistic regression analysis revealed that GG genotype was an independent risk factor of diabetic nephropathy( P < 0. 05) . Conclusion PON2 A148G polymorphism is associated with the pathogenesis of DN.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2002年第6期422-424,共3页 Chinese Journal of Nephrology
关键词 2型糖尿病 糖尿病肾病 对氧磷酯酶 基因多态性 Type 2 diabetes mellitus Nephropathy Paraoxonase 2 Gene Polymorphism
  • 相关文献

参考文献10

  • 1Sakai T, Matauura B, Onji M. Serum paraoxonase activity and genotype distribution in Japanese patients with diabetes mellitus.Intern Med, 1998, 37: 581-584.
  • 2Ikeda Y, Suehiro T, Inoue M, et al. Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus. Metabolism, 1998, 47:598-602.
  • 3Pinizzotto M, Castillo E, Fiaux M, et al. Paraoxonase 2 polymorphism are associated with diabetic nephropathy in type Ⅱ diabetes. Diabetologia, 2001, 44: 104-107.
  • 4Canani LH, Araki S, Warram JH, et al. Comment-to: Pinizzotto M, Castillo E, Fiaux M, Temler E, Gaillard RC, Ruiz J(2001).Paraoxonase 2 polymorphism are associated with diabetic nephropathy in type Ⅱ diabetes. Diabetologia, 2001,44: 104-107;1062-1064.
  • 5Humbert R, Alder DA, Disteche CM, et al. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet, 1993, 3:73-76.
  • 6Mackness B, Durrington PN, Abuashia B, et al. Low paraoxonase activity in type Ⅱ diabetes mellitus complicated by retinopathy.Clin Sci(Colch), 2000, 98:355-363.
  • 7Kohno M, Ohmori K, Wada Y, et al. Inhibition by eicosapentaenoic acid of oxidized-LDL and lysophosphatidylcholineinduced human coronary artery smooth muscle cell production of endothelin. J Vasc Res, 2001, 38: 379-388.
  • 8Sharma K, Ziyadeh FN. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin Nephrol, 1997, 17: 80-92.
  • 9Yokoyama H, Deckert T. Central role of TGF-β in the pathogenesis of diabetic nephropathy and macrovascular complications: a hypothesis. Diabet Med, 1996, 13:313-320.
  • 10Ziyadeh FN, Han DC, Cohen JA, et al. Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-β system.Kidney Int, 1998, 53:631-638.

同被引文献103

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部